Prognostic (and partly predictive) factors in early, non-metastatic IBC that has not metastasized are: age, tumor size, nodal status, tumor grade, proliferation, angioinvasion, hormone receptor (HR) status, HER2 status [7], and molecular subtype [8]. The gene discussed is NR4A1; the disease is inflammatory breast carcinoma.